UCAM and IMIB patent a new use for two drugs to prevent and treat covid-19
Researchers from the two institutions have carried out in-vitro development with Zeaxanthin and Kukoamine A to prevent the virus from entering the cell
The patent for an anti-tumour drug is being developed in the Region of Murcia, with clinical trials to be carried out on a global scale
The researchers belong to the Universidad Católica de Murcia, the Murcian Institute of Biosanitary Research and the University of Granada.